Celemics - Crunchbase Company Profile & Funding

Q: Where is Celemics's headquarters?

Celemics is located in Seoul, Seoul-t'ukpyolsi, South Korea.

Q: Who invested in Celemics?

Celemics is funded by WONIK Investment Partners.

Q: When was the last funding round for Celemics?

Celemics closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has Celemics raised to date?

Celemics has raised obfuscated.

Overview

Celemics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Celemics

CB Rank

133674

Celemics is a biotech company that develops DNA-based materials through novel sequencing technologies.

Founded

obfuscation

Public

Post-IPO Equity

Seoul, Seoul-t'ukpyolsi, South Korea

51-100

www.celemics.com

Bioinformatics

Biopharma

Biotechnology

Genetics

Life Science

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Post-IPO Debt

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Sunghoon Kwon: Founder and Adviser
Past Role: Lawrence Berkeley National Laboratory, Postdoctorial Fellow
Hyoki Kim: Co-Founder and CEO
Past Role: Republic of Korea Marine Corps, Military Service

Details

Legal Name

Celemics, Inc.

Operating Status

Active

Stock Symbol

KOSDAQ:331920

Company Type

For Profit

Founders

Hyoki Kim, Sunghoon Kwon

About the Company

Celemics is a biotechnology research company that offers sequencing, antibody library sequencing, and immune profiling. They offer services for diagnostics of inherited diseases, microbiology virus research, molecular breeding antibody discovery, and cancer research.

Phone Number

+82-2-6746-8067

Predictions & Insights

Products & Services

Whole Exome Sequencing

A sequencing service that targets the entire human exome to identify genetic variants with comprehensive coverage and uniformity.

NGS Target Enrichment Panels

Hybridization-based panels that selectively capture specific genomic regions for targeted next-generation sequencing.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Celemics	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Celemics	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Celemics	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Celemics	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Celemics	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Celemics	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Celemics	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Celemics	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Celemics	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Celemics	—	obfuscated obfuscation	—	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
WONIK Investment Partners	—	Venture Round - Celemics	—
WONIK Investment Partners	—	Venture Round - Celemics	—
WONIK Investment Partners	—	Venture Round - Celemics	—
WONIK Investment Partners	—	Venture Round - Celemics	—
WONIK Investment Partners	—	Venture Round - Celemics	—